ZA977326B - Tetrahydroquinoline derivatives - Google Patents
Tetrahydroquinoline derivativesInfo
- Publication number
- ZA977326B ZA977326B ZA977326A ZA977326A ZA977326B ZA 977326 B ZA977326 B ZA 977326B ZA 977326 A ZA977326 A ZA 977326A ZA 977326 A ZA977326 A ZA 977326A ZA 977326 B ZA977326 B ZA 977326B
- Authority
- ZA
- South Africa
- Prior art keywords
- tetrahydroquinoline derivatives
- tetrahydroquinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9617305.9A GB9617305D0 (en) | 1996-08-17 | 1996-08-17 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977326B true ZA977326B (en) | 1999-02-15 |
Family
ID=10798623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA977326A ZA977326B (en) | 1996-08-17 | 1997-08-14 | Tetrahydroquinoline derivatives |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6479488B1 (hu) |
| EP (1) | EP0922034B1 (hu) |
| JP (1) | JP4108129B2 (hu) |
| KR (1) | KR100552864B1 (hu) |
| CN (1) | CN1131214C (hu) |
| AP (1) | AP877A (hu) |
| AR (1) | AR008296A1 (hu) |
| AT (1) | ATE221052T1 (hu) |
| AU (1) | AU724473B2 (hu) |
| BR (1) | BR9711311B1 (hu) |
| CA (1) | CA2264118C (hu) |
| CO (1) | CO4900066A1 (hu) |
| CZ (1) | CZ296250B6 (hu) |
| DE (1) | DE69714265T2 (hu) |
| DK (1) | DK0922034T3 (hu) |
| EA (1) | EA001704B1 (hu) |
| ES (1) | ES2181030T3 (hu) |
| GB (1) | GB9617305D0 (hu) |
| HU (1) | HU225797B1 (hu) |
| ID (1) | ID18095A (hu) |
| IL (1) | IL128141A0 (hu) |
| IS (1) | IS4953A (hu) |
| MY (1) | MY116952A (hu) |
| NO (1) | NO312241B1 (hu) |
| NZ (1) | NZ333812A (hu) |
| PE (1) | PE107098A1 (hu) |
| PL (1) | PL194532B1 (hu) |
| PT (1) | PT922034E (hu) |
| SI (1) | SI0922034T1 (hu) |
| TR (1) | TR199900336T2 (hu) |
| TW (1) | TW449582B (hu) |
| WO (1) | WO1998007704A1 (hu) |
| YU (1) | YU6799A (hu) |
| ZA (1) | ZA977326B (hu) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706294D0 (en) * | 1997-03-26 | 1997-05-14 | Glaxo Wellcome Spa | Heterocyclic compound |
| MY125037A (en) | 1998-06-10 | 2006-07-31 | Glaxo Wellcome Spa | 1,2,3,4 tetrahydroquinoline derivatives |
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| GB9929037D0 (en) * | 1999-12-08 | 2000-02-02 | Glaxo Wellcome Spa | Heterocyclic derivatives |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| MXPA04006281A (es) * | 2001-12-28 | 2004-09-27 | Acadia Pharm Inc | Analogos de tetrahidroquinolina como agonistas muscarinicos. |
| MXPA05007784A (es) * | 2003-01-23 | 2005-09-30 | Acadia Pharm Inc | Empleo de la n-desmetilclozapina para tratar las enfermedades neuropsiquiatricas humanas. |
| US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20060233843A1 (en) * | 2003-02-19 | 2006-10-19 | Conn P J | Treatment of psychosis with a muscarinic m1 receptor ectopic activator |
| CN101962369A (zh) * | 2003-12-22 | 2011-02-02 | 阿卡蒂亚药品公司 | 氨基取代的二芳基[a,d]环庚烯类似物作为毒蕈碱激动剂的用途及神经精神疾病的治疗方法 |
| CN1950346A (zh) * | 2004-04-01 | 2007-04-18 | 阿卡蒂亚药品公司 | N－去甲基氯氮平的晶形 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| KR101136183B1 (ko) * | 2005-07-22 | 2012-04-17 | 모찌다 세이야쿠 가부시끼가이샤 | 신규 헤테로시클리덴 아세트아미드 유도체 |
| WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
| US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
| EP2324838A1 (en) * | 2005-09-12 | 2011-05-25 | Abela Pharmaceuticals, Inc. | Compositions Comprising Dimethyl Sulfoxide (DMSO) |
| AU2006291134C1 (en) | 2005-09-12 | 2013-08-15 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same |
| US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
| US9855212B2 (en) | 2009-10-30 | 2018-01-02 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases |
| EP2763676B1 (en) | 2011-10-03 | 2019-12-25 | The University of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93610A0 (en) | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| CA2232509A1 (en) * | 1995-09-29 | 1997-04-10 | Glaxo Wellcome Spa | Tetrahydroquinolines as nmda antagonists |
-
1996
- 1996-08-17 GB GBGB9617305.9A patent/GB9617305D0/en active Pending
-
1997
- 1997-08-14 IL IL12814197A patent/IL128141A0/xx not_active IP Right Cessation
- 1997-08-14 ES ES97943809T patent/ES2181030T3/es not_active Expired - Lifetime
- 1997-08-14 ZA ZA977326A patent/ZA977326B/xx unknown
- 1997-08-14 AT AT97943809T patent/ATE221052T1/de not_active IP Right Cessation
- 1997-08-14 CN CN97197233A patent/CN1131214C/zh not_active Expired - Fee Related
- 1997-08-14 AU AU45518/97A patent/AU724473B2/en not_active Ceased
- 1997-08-14 SI SI9730404T patent/SI0922034T1/xx unknown
- 1997-08-14 CZ CZ0052999A patent/CZ296250B6/cs not_active IP Right Cessation
- 1997-08-14 DE DE69714265T patent/DE69714265T2/de not_active Expired - Lifetime
- 1997-08-14 US US09/147,568 patent/US6479488B1/en not_active Expired - Fee Related
- 1997-08-14 PL PL97331562A patent/PL194532B1/pl not_active IP Right Cessation
- 1997-08-14 PT PT97943809T patent/PT922034E/pt unknown
- 1997-08-14 TR TR1999/00336T patent/TR199900336T2/xx unknown
- 1997-08-14 PE PE1997000718A patent/PE107098A1/es not_active Application Discontinuation
- 1997-08-14 KR KR1019997001280A patent/KR100552864B1/ko not_active IP Right Cessation
- 1997-08-14 BR BRPI9711311-5A patent/BR9711311B1/pt not_active IP Right Cessation
- 1997-08-14 CO CO97046782A patent/CO4900066A1/es unknown
- 1997-08-14 YU YU6799A patent/YU6799A/sh unknown
- 1997-08-14 EP EP97943809A patent/EP0922034B1/en not_active Expired - Lifetime
- 1997-08-14 AP APAP/P/1999/001459A patent/AP877A/en active
- 1997-08-14 NZ NZ333812A patent/NZ333812A/xx active Application Revival
- 1997-08-14 ID IDP972834A patent/ID18095A/id unknown
- 1997-08-14 WO PCT/EP1997/004440 patent/WO1998007704A1/en active IP Right Grant
- 1997-08-14 CA CA002264118A patent/CA2264118C/en not_active Expired - Fee Related
- 1997-08-14 AR ARP970103703A patent/AR008296A1/es active IP Right Grant
- 1997-08-14 EA EA199900121A patent/EA001704B1/ru not_active IP Right Cessation
- 1997-08-14 HU HU9903108A patent/HU225797B1/hu not_active IP Right Cessation
- 1997-08-14 DK DK97943809T patent/DK0922034T3/da active
- 1997-08-14 MY MYPI97003742A patent/MY116952A/en unknown
- 1997-08-14 JP JP51037298A patent/JP4108129B2/ja not_active Expired - Fee Related
- 1997-08-30 TW TW086112442A patent/TW449582B/zh not_active IP Right Cessation
-
1999
- 1999-01-22 IS IS4953A patent/IS4953A/is unknown
- 1999-02-16 NO NO19990723A patent/NO312241B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9500745A0 (en) | Quinoline derivatives | |
| HRP970174B1 (en) | 6-phenylpyridil-2-amine derivatives | |
| AP9701156A0 (en) | 6-phenylpyridyl-2-amine derivatives | |
| IL125379A (en) | 19-nor-pregnene derivatives | |
| ZA977326B (en) | Tetrahydroquinoline derivatives | |
| ZA974053B (en) | Alkylaminobenzothiazole and -benzoxazole derivatives | |
| HUP9701835A3 (en) | Vinyl-pirrolidinone-cephalosporin derivatives | |
| IL129418A0 (en) | 2-Methoxyphenylpiperazine derivatives | |
| GB9404378D0 (en) | Quinoline derivatives | |
| IL125149A0 (en) | Pyrazol-4-yl-hetaroyl derivatives | |
| PL334558A1 (en) | Cephalosporinic derivatives | |
| ZA954269B (en) | Quinoline derivatives | |
| HU9701479D0 (en) | N-benzylazolium derivatives | |
| GB9402275D0 (en) | Quinoline derivatives | |
| ZA972051B (en) | Benzodiazonine derivatives | |
| GB9413150D0 (en) | Quinoline derivatives | |
| GB9600063D0 (en) | Guaridine derivatives | |
| GB9603226D0 (en) | Heterocyclyl-ergoline derivatives | |
| ZA971911B (en) | 2-thioxo-tetrahydropyrimidin-4-one derivatives | |
| IL130283A0 (en) | Polysaccharide-peptide derivatives | |
| GB9702049D0 (en) | Tetrahhydroisoquinoline derivatives | |
| HU9601036D0 (en) | Aryl-sulfonyl-hydroxamic-acid derivatives | |
| GB9402306D0 (en) | Quinoline derivatives | |
| IL139301A0 (en) | Quinoline derivatives | |
| GB9413937D0 (en) | Quinoline derivatives |